The determination of AGE-peptides by flow injection assay, a practical marker of diabetic nephropathy
- 30 October 2001
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 313 (1-2) , 69-75
- https://doi.org/10.1016/s0009-8981(01)00651-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patientsMetabolism, 1998
- Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.Journal of Clinical Investigation, 1997
- Recent Progress in Advanced Glycation End Products and Diabetic ComplicationsDiabetes, 1997
- Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix.Journal of Clinical Investigation, 1997
- Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitusMetabolism, 1997
- Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapyKidney International, 1997
- Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine.Proceedings of the National Academy of Sciences, 1996
- The role of advanced glycosylation end-products in the pathogenesis of atherosclerosisNephrology Dialysis Transplantation, 1996
- Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathyHuman Pathology, 1995
- ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGINGAnnual Review of Medicine, 1995